Literature DB >> 448889

Selective transsphenoidal adenomectomy in women with galactorrhea-amenorrhea.

K D Post, B J Biller, L S Adelman, M E Molitch, S M Wolpert, S Reichlin.   

Abstract

Thirty women with prolactin (PRL)-secreting adenomas underwent selective adenomectomy via a transsphenoidal route. All had abnormal sella polytomes or visual fields, amenorrhea with low basal serum gonadotropin levels despite decreased serum estradiol concentrations, and elevated basal serum PRL levels with blunted PRL response to neuroendocrine stimulation tests )thyrotropin-releasing hormone, levodopa, chlorpromazine, and hypoglycemia). Of 17 patients with microadenomas, 14 (82.4%) were cured and three (17.6%) improved. None were unchanged or worse. Three (60%) of five patients with larger, but still intrasellar tumors, had normalization of PRL levels, return of menses, and resolution of galactorrhea. The patients with tumors extending out of the sella did not fare as well. Overall, 21 (70%) were cured, six (20%) improved, two (6.7%) were unchanged, and the condition of one (3.3%) became worse. All preoperative neurologic deficits resolved. Postoperative complications were minimal with no neurologic morbidity. When tumors are small, surgical results are excellent with minimal risk.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 448889

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  6 in total

1.  Obstetrics and gynecology-epitomes of progress: the prolactinoma problem: long-term issues and short-term answers.

Authors:  E M Gold
Journal:  West J Med       Date:  1981-06

2.  Enlarged adenomectomy for enclosed prolactinomas: a preliminary study of 26 cases.

Authors:  F Grisoli; T Brue; N Graziani; R Costa; J Trouillas; D Begou; P Jaquet
Journal:  Acta Neurochir (Wien)       Date:  1990       Impact factor: 2.216

Review 3.  Therapeutic applications of bromocriptine in endocrine and neurological diseases.

Authors:  K Y Ho; M O Thorner
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

4.  Prolactinoma in a man following industrial exposure to estrogens.

Authors:  S H Baron; J R Sowers; M Feinberg
Journal:  West J Med       Date:  1983-05

5.  Nerve growth factor suppresses the transforming phenotype of human prolactinomas.

Authors:  C Missale; F Boroni; M Losa; M Giovanelli; A Zanellato; R Dal Toso; A Balsari; P Spano
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

6.  Recovery of visual and endocrine function following transsphenoidal surgery of large nonfunctioning pituitary adenomas.

Authors:  M Marazuela; B Astigarraga; A Vicente; J Estrada; C Cuerda; J García-Uría; T Lucas
Journal:  J Endocrinol Invest       Date:  1994-10       Impact factor: 4.256

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.